Finoriq research workspace
Bluejay Diagnostics, Inc. (BJDX) SEC Filings & Filing Highlights
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. Review BJDX SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
- Company
- Bluejay Diagnostics, Inc. (BJDX)
- Ticker
- BJDX
- Market Cap
- $1.3M
- Latest Price
- $1.25
- Industry
- Medical Devices
Bluejay Diagnostics, Inc. (BJDX) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Bluejay Diagnostics, Inc. (BJDX).
| Event | Form | Date |
|---|---|---|
| The voting results for the proposal were as followsOn June 9, 2026, the Company held the Annual Meeting. As of April 28, 2026, the record date for the Annual Meeting, there were 1,034,715 sh... | 8-K5.07 | 2026-06-09 |
| On June 9, 2026, Bluejay Diagnostics, Inc. (the “Company”) held its 2026 annual meeting of stoc...On June 9, 2026, Bluejay Diagnostics, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”). At the Annu... | 8-K5.02 | 2026-06-09 |
| BLUEJAY DIAGNOSTICS ANNOUNCES UP TO $23.6 MILLION PRIVATE PLACEMENTBLUEJAY DIAGNOSTICS ANNOUNCES UP TO $23.6 MILLION PRIVATE PLACEMENT | 8-K8.01 | 2026-06-08 |
| H.C. Wainwright & Co. served as the exclusive placement agent for the private placementOn June 2, 2026, Bluejay Diagnostics, Inc. (the “Company”), in connection with a private placement of the Company’s securities, entered int... | 8-K1.01 | 2026-06-08 |
| Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic PartnershipBluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership | 8-K7.01 | 2026-06-02 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.